Israel (IL)

Heterozygous UBR5 variants result in a neurodevelopmental syndrome with developmental delay, autism, and intellectual disability (2025) Sabeh P, Dumas SA, Maios C, Daghar H, Korzeniowski M, Rousseau J, Lines M, et al. Journal article The Lucerne Toolbox 3: digital health and artificial intelligence to optimise the patient journey in early breast cancer-a multidisciplinary consensus. (2025) Pfob A, Pinker K, Vaz-Luis I, Di Meglio A, Cardoso MJ, Curigliano G, Gentilini OD, et al. Journal article, Review article Anterior temporal lobectomy and selective AmygdaloHippocampectomy complications across Europe: review, meta-analysis, and Delphi consensus. (2025) Karagianni MD, Schijns OE, Brotis A, Tasiou A, Auer C, Blauwblomme T, Budke M, et al. Journal article, Review article A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis. (2025) Bjørkekjær HJ, Bruni C, Broch K, Brunborg C, Carreira PE, Airò P, Simeón-Aznar CP, et al. Journal article Fourier-Domain Low-Coherence Interferometry with Undetected Mid-Infrared Photons in the High-Gain Regime (2025) Zotti G, Hashimoto K, Horoshko DB, Kolobov MI, Michael Y, Gefen Z, Chekhova MV Conference contribution The Mystery of Dibenzoterrylene: a Clar-interlocked Biphenalenyl Biradical (2025) Kalinina EA, Kalinin MA, Sharapa DI, Maid H, Freidzon A, Haeri HH, Hinderberger D, et al. Journal article Paroxysmal slow wave events as a diagnostic biomarker for epilepsy: Lessons from rural Zambia (2025) Malunga A, Lash S, Abu-Ahmad A, Alhadeed L, Benninger F, Ben-Arie G, Fearns N, et al. Journal article Optimization of Pulsed Saturation Transfer MR Fingerprinting (ST MRF) Acquisition Using the Cramér–Rao Bound and Sequential Quadratic Programming (2025) Vladimirov N, Zaiß M, Perlman O Journal article In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma (2025) Salvermoser L, Schäfer JN, Goldberg SN, Kazmierczak PM, Gröper MN, Linden PF, Öcal E, et al. Journal article Upadacitinib Maintenance Therapy in Crohn's Disease: Final Results From the Randomized Phase 3 U-ENDURE Study (2025) Panaccione R, Regueiro M, Lee SD, Atreya R, Pedersen G, Broide E, Rodriguez C, et al. Journal article